Home

Glaxosmithkline Pharmaceuticals Ltd EPS

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

EPS

₹ 51.59

Last updated on: Jun 27, 2025

Key Highlights

  • The Earning per Share of Glaxosmithkline Pharmaceuticals Ltd is ₹ 51.59 as of 27 Jun 25 .
  • The earning per share of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 7.04 to ₹ 15.52 over 8 quarters. This represents a CAGR of 48.48% .

Historical Earning per Share of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Market Cap

58,575 Cr

EPS

51.6

P/E Ratio (TTM)

67.0

P/B Ratio (TTM)

30.0

Day’s High

3500.0

Day’s Low

3297.35

DTE

0.0

ROE

47.5

52 Week High

3515.95

52 Week Low

1924.3

ROCE

64.3

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Jun 20253457.7
26 Jun 20253297.35
25 Jun 20253262.85
24 Jun 20253227.35
23 Jun 20253169.3
20 Jun 20253205.2
19 Jun 20253194
18 Jun 20253284.7
17 Jun 20253252.3
16 Jun 20253366.5

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

58,576

Asset Value

Value addition

22.8 X

2,460

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Glaxosmithkline Pharmaceuticals Ltd58575
Sun Pharmaceutical Industries Ltd405008
Divis Laboratories Ltd176748
Cipla Ltd121378
Torrent Pharmaceuticals Ltd113185
Dr Reddys Laboratories Ltd108592

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to conduct board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M

Read more

19 Apr 25

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

FAQs for EPS of Glaxosmithkline Pharmaceuticals Ltd

What is the EPS of Glaxosmithkline Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Glaxosmithkline Pharmaceuticals Ltd is 51.59. An EPS is the amount of net income attributed to each share of a common stock.

How is Glaxosmithkline Pharmaceuticals Ltd EPS calculated?

The EPS of Glaxosmithkline Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glaxosmithkline Pharmaceuticals Ltd report its EPS?

Glaxosmithkline Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glaxosmithkline Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Glaxosmithkline Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glaxosmithkline Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Glaxosmithkline Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions